Twitter feed

Thank you @SanfordBishop, @JeffFortenberry & the @AppropsDems Cmt for passage of the FY20 Agriculture/FDA funding bill which includes $25M for @FDAOncology Center of Excellence! Read our testimony to the Cmt: #ASCOinAction

More Funding Needed for Researchers Making Progress Against Cancer,

ASCO submitted testimony to the U.S. House and Senate Appropriations Committees urging them to increase funding for the National Institutes of Health,...


Reminder: Abstract submission deadline for the 12th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved is July 12. https://t.co/8beMkYIHnK

Congratulations to @Carle_org Cancer Center of #Urbana, IL on their recent #QOPI Re-Certification! https://t.co/Qk4emh7fmb #QOPICertified

It's National Cancer Survivor Month and SSP advocate @diane_nathaniel celebrates survivorship by sharing her story with the world, advocating for cancer fighters, survivors and those who have lost their battle to this disease. #CelebrateSurvivorship

RT @CR_AACR: Fusions involving NTRK have been shown to be therapeutically relevant in certain #cancers; accurate detection is critical.
@JackieHechtman and J. Solomon @sloan_kettering discuss diagnostic platforms in this #OnlineFirst #ReviewArticle:

It's National Cancer Survivor Month and SSP advocate and Colorectal Cancer survivor Howard celebrates survivorship by staying positive, staying active, staying hydrated and staying strong! #CelebrateSurvivorship

Abstract submission deadline is June 26 for the Advances in Ovarian Cancer Research Conference in Atlanta, Sept. 13-16. https://t.co/dO5wMNixU6 #AACROvCA19

RT @AACR_CEO: Great to see Jennifer Grandis and @AACR Past President Liz Jaffee at our Future of Cancer Research Innovation Summit on Combination Therapies in Washington, DC. I am grateful to all of the summit participants for their leadership in this critical area.

Join the AACR, @MoffittNews, @BidenCancer, @ACSCAN, @ASCO, @AACI_Cancer, @preventcancer, @StJude, & @uicc on June 27 at noon ET for a panel discussion on how to eliminate HPV-related cancers. #EndHPVcancers
Register: https://t.co/r3w5Vr9QGp
Learn more: https://t.co/JVAaaj0tGe

Chaired by Deb Schrag, @DanaFarber, as well as, @SeanKhozin and Pallavi Mishra-Kalyani, @FDAOncology , the FDA-AACR Real-world Evidence Workshop will examine use cases in which RWE was utilized to improve or accelerate treatment development. https://t.co/MdLYr6KRJ2 #OCEAACRRWE

Recent publications

Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun.

Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature.

All publications


Dr. Jänne, Director Belfer Center for Applied Cancer Science, presents phase I data for HER3 targeting ADC in patients with EGFR mutant lung cancer patients   at the 2019 ASCO Annual Meeting


Target identification and validation image
Target identification and validation
Photo of scientist carefully adding fluid to multiple test tubes
Drug discovery and development
Photo of Belfer Center researcher working at computer
Clinical science and correlatives

Strategic alliances

Graphic showing circular relationship of research, medicine, and industry

Our strategic alliances drive research innovations and lead to improved therapies to benefit cancer patients

Collaborate with us

Our people

Background image is a collage of photos showing Belfer Center members

Donor highlight

Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the development of revolutionary therapies to treat cancer. We are grateful for their vision and incredible support.

Photo of donors, Mr. and Mrs Belfer